相关实验视频
Updated: Jul 19, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
253
粉样蛋白PET成像在痴呆症中的患者相关益处:德国随机覆盖范围与证据开发研究ENABLE的推理和设计
Stefan J Teipel1,2, Annika Spottke3, Henning Boecker3
1Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald Rostock Germany.
Alzheimer's & dementia (New York, N. Y.)
|August 10, 2023
概括
这项研究调查了粉样质正子发射断层扫描 (PET) 对痴呆症诊断和患者在常规护理中的功能的影响. 在24个月内,ENABLE将评估PET扫描如何影响日常生活活动.
科学领域:
- 神经学 神经学
- 医疗成像医学成像
- 临床试验 临床试验
背景情况:
- 在常规痴呆症护理中,粉样质正子辐射断层扫描 (PET) 的诊断实用性和影响尚不清楚.
- 了解粉样PET对患者功能状态的影响对于临床决策至关重要.
研究的目的:
- 评估粉样蛋白PET在痴呆症病因诊断中的有效性.
- 评估粉胺PET对常规护理患者的功能状态和临床结果的影响.
- 为医疗保健提供者和支付人提供关于在痴呆症管理中使用粉样蛋白PET的信息.
主要方法:
- 该研究是一个随机控制的双臂覆盖与证据开发 (CED) 试验.
- 1126名患有不清楚病因的轻度至中度痴呆症的患者随机分配到粉样蛋白PET或没有粉样蛋白PET组.
- 患者被跟踪了24个月,主要终点是18个月的日常生活中的功能活动.
主要成果:
- 该研究旨在提供有关粉样PET在常规护理环境中的患者相关影响的数据.
- 二级终点包括诊断的变化,诊断信心和认知/临床结果.
- 预计结果将指导痴呆症诊断的临床实践和医疗保健政策.
结论:
- 该研究旨在澄清粉样PET在改善痴呆症诊断和患者护理方面的作用.
- 结果将支持医生和医疗保健支付人关于粉样蛋白PET利用的基于证据的决定.
- 这项研究有助于优化痴呆症患者的日常护理.
相关概念视频
Positron Emission Tomography
4.3K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.3K
Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521
Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
Imaging Studies II: Positron Emission Tomography and Scintigraphy
156
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
156
Radiological Investigation III: Pulmonary Angiogram and PET Scan
115
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
115

